UCLA imaging study suggests Alzheimer's drug may help mild memory loss

July 30, 2008

Alzheimer's disease is the end result of gradual, progressive brain aging. Positron emission technology (PET) scans of patients' brains typically reveal a decreased rate of metabolism, a hallmark of the disorder.

A small sample of adults with mild age-related memory loss was randomly assigned a daily placebo or Aricept, a drug that treats Alzheimer's symptoms. Both groups underwent PET brain scans before and after 18 months of treatment. The brains of people given Aricept showed an increased rate of metabolism and looked more normal than the brains of those who took the placebo. Both groups scored the same on memory tests, however, implying that PET scans may be more sensitive than neuropsychological tests in detecting drugs' effects.

The research suggests that the treatment of early symptoms of memory loss may protect the brain and help people with mild age-related memory impairment. The finding also shows how PET offers researchers a tool for tracking the effectiveness of drugs prescribed to treat age-related cognitive decline.

The findings will be presented July 30 at the "Hot Topics" poster session of the International Conference on Alzheimer's Disease 2008, hosted by the Alzheimer's Association.

Source: University of California - Los Angeles

Explore further: Case study on Alzheimer's disease looks at progression before and after death

Related Stories

Cloning whistle-blower: little change in S. Korea

October 24, 2014

The whistle-blower who exposed breakthrough cloning research as a devastating fake says South Korea is still dominated by the values that allowed science fraudster Hwang Woo-suk to become an almost untouchable national hero.

Optical brain scanner goes where other brain scanners can't

May 19, 2014

Scientists have advanced a brain-scanning technology that tracks what the brain is doing by shining dozens of tiny LED lights on the head. This new generation of neuroimaging compares favorably to other approaches but avoids ...

In Alzheimer's diagnosis, many heads better than one

January 26, 2011

In a marriage of two disciplines that don’t often overlap — politics and medicine — a study by Matthew Gabel, PhD, professor of political science in Arts & Sciences at Washington University in St. Louis, finds ...

FDA panel sees promise in Alzheimer's imaging drug

January 20, 2011

(AP) -- A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical designed to help screen for Alzheimer's disease could be useful pending additional study and training for physicians.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.